A novel pharmaceutical preparation of Tripterygium wilfordii Hook. f. regulates macrophage polarization to alleviate inflammation in rheumatoid arthritis
Journal of Pharmacy and Pharmacology · 01.11.2023 · 75 (11) · 1442-1457
DOI: 10.1093/jpp/rgad078 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 01.11.2023. Verfasst von Lei Wan und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230038, China. Hauptthemen laut MEDLINE: Interleukin-10, Arthritis, Rheumatoid. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Xin'an Medical Ministry of Education Key Laboratory, Natural Science Research Project of Colleges and Universities of Anhui Province.
Abstract (Originalsprache)
Objectives
To validate the enhanced therapeutic effect of Tripterygium wilfordii Hook. f. (TWHF) in the treatment of rheumatoid arthritis (RA) by restoring homeostasis of M1/M2 macrophages.
Methods
This study, using random walk models and network pharmacology, examined the molecular targets and mechanism of TWHF in RA. Based on clinical observations and experiments in arthritis animal models, the effects of TWHF on macrophage polarization, related signal pathways, and targets were examined. Triptolide, a component of TWHF, was used to intervene arthritis rats. Key findings Network pharmacological analysis revealed the key RA target genes related to TWHF. TWHF showed a strong correlation with the improvement of inflammatory indicators. TWHF inhibited the factors secreted by M1 macrophages such as IL-1β, IL-6, CXCL8, TNF-α, and VEGF-A, but promoted IL-10 from M2 macrophages. Quantitative liquid-phase chip assay showed that triptolide reduced the levels of TNF-α, CXCL2, and VEGF, while IL-4 and IL-10 were increased in arthritis model. Meanwhile, triptolide inhibited the NF-κB, PI3K/AKT, and p38 MAPK signaling pathways, which in turn improved the RA joint inflammation and fixed immune imbalance.
Conclusions
Triptolide downregulate the expression of M1 macrophage-secreted factors that inhibit the overactivation of inflammatory signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230038, China.
- Key Laboratory of Xin'an Medical Education Ministry, Anhui University of Chinese Medicine, Hefei 230036, China.
- College of Traditional Chinese Medicine, Anhui University of Chinese Medicine, Hefei 230012, China.
ORCID-Profile: Lei Wan
Förderung
- National Natural Science Foundation of China
- Xin'an Medical Ministry of Education Key Laboratory
- Natural Science Research Project of Colleges and Universities of Anhui Province
- University Natural Science Research Project of Anhui Province
- Provincial Education Teaching Reform Research Project of Anhui Higher Education Quality
- Xin’an Medical Ministry of Education Key Laboratory
Zitieren
APA
Wan, L., Liu, J., Huang, C., Wang, K., Zhu, Z., & Li, F. (2023). A novel pharmaceutical preparation of Tripterygium wilfordii Hook. f. regulates macrophage polarization to alleviate inflammation in rheumatoid arthritis. Journal of Pharmacy and Pharmacology, 75(11), 1442-1457. https://doi.org/10.1093/jpp/rgad078
Vancouver
Wan L, Liu J, Huang C, Wang K, Zhu Z, Li F. A novel pharmaceutical preparation of Tripterygium wilfordii Hook. f. regulates macrophage polarization to alleviate inflammation in rheumatoid arthritis. Journal of Pharmacy and Pharmacology. 2023;75(11):1442-1457. doi:10.1093/jpp/rgad078
BibTeX
@article{Wan2023,
author = {Wan, Lei and Liu, Jian and Huang, Chuanbing and Wang, Kun and Zhu, Ziheng and Li, Fangze},
title = {A novel pharmaceutical preparation of Tripterygium wilfordii Hook. f. regulates macrophage polarization to alleviate inflammation in rheumatoid arthritis},
journal = {Journal of Pharmacy and Pharmacology},
year = {2023},
volume = {75},
number = {11},
pages = {1442--1457},
doi = {10.1093/jpp/rgad078}
}
EUVIMED